BDX - Becton Dickinson and Company

Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.

52W High

$249.34

52W Low

$162.35

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.30

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

35.24

Forward P/E (<15 better)

12.52

EV/EBITDA (<8 favorable)

14.99

EV/Revenue (<3 favorable)

3.45

P/S (TTM) (<3 favorable)

2.58

P/B (<3 favorable)

2.17

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.57%

Institutions (25–75% balanced)

92.26%

Shares Outstanding

286,627,000

Float

285,994,000

Dividend Yield (2–6% sweet spot)

0.02%

Ex‑Dividend Date

2025-09-08

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

21,386,000,000

Gross Profit (TTM)

10,085,000,000

EPS (TTM)

5.46

Profit Margin (>10% good)

0.07%

Operating Margin (TTM) (higher better)

0.18%

ROE (TTM) (>15% strong)

0.06%

EPS YoY (Quarterly) (>10% good)

0.19

Revenue YoY (Quarterly) (>8% good)

0.10

Momentum

Bearish momentum

Value

0.5505

1.0338

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025